News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
205 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18692)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
2 (1)
4 (5)
5 (169)
6 (158)
7 (87)
10 (161)
11 (185)
12 (154)
13 (136)
14 (84)
17 (148)
18 (173)
19 (149)
20 (149)
21 (88)
24 (148)
25 (176)
26 (170)
27 (205)
28 (129)
31 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
FDA
FDA Approves Eisai Inc.'s FYCOMPA (Perampanel) For Use As Monotherapy For The Treatment Of Partial-Onset Seizures
July 27, 2017
·
9 min read
Drug Development
Soligenix Initiates Pivotal Phase III Clinical Trial Of SGX942 (Dusquetide) For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients
July 27, 2017
·
13 min read
Drug Development
Quark Pharmaceuticals Inc. Reports Positive Results From A Phase II Study To Evaluate The Efficacy And Safety Of QPI-1002 For The Prevention Of Acute Kidney Injury (AKI) In Subjects At High Risk Of AKI Following Cardiac Surgery
July 27, 2017
·
5 min read
Drug Development
Akcea Therapeutics And Ionis Pharma Announce Submission Of Marketing Authorization Application For Volanesorsen To The EMA
July 27, 2017
·
10 min read
Business
Bristol-Myers Squibb Reports Second Quarter Financial Results
July 27, 2017
·
1 min read
Drug Development
Eiger Biopharma Announces FDA Fast Track Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection
July 27, 2017
·
4 min read
Genetown
Moderna Provides Update On mRNA Rare Disease R&D Strategy
July 27, 2017
·
3 min read
Valeant Announces U.S. Launch Of SILIQ (Brodalumab) Injection
July 27, 2017
·
6 min read
Deals
ICON Acquires Mapi Group
July 27, 2017
·
4 min read
Biotech Beach
Imprimis Patent-Pending Dropless And LessDrops Formulations Exceed One Million Patient Eyes Milestone
July 27, 2017
·
7 min read
Previous
2 of 21
Next